[Conditional medium of gastric cancer mesenchymal stem cells promotes PD-L1 expression in gastric cancer cells and tumor growth via upregulating VGLL4]
- PMID: 35583061
[Conditional medium of gastric cancer mesenchymal stem cells promotes PD-L1 expression in gastric cancer cells and tumor growth via upregulating VGLL4]
Abstract
Objective To investigate whether conditional medium of gastric cancer mesenchymal stem cells (GCMSCs-CM) could up-regulate the expression of programmed death 1 ligand 1 (PD-L1) and promote gastric cancer progression by vestigial-like protein 4 (VGLL4). Methods Western blot was used to detect the expression of VGLL4 in SGC-7901, HGC-27 and MGC-803 gastric cancer cells. The expression of VGLL4 in HGC-27 and SGC-7901 cells was inhibited by being transfected with VGLL4 specific siRNA and plasmid was used to overexpress VGLL4 in SGC-7901 cells. The gastric cancer cells were divided into control group, GCMSCs-CM treatment group, VGLL4 interference or overexpression group, and VGLL4 interference followed by GCMSCs-CM treatment group. The expression of PD-L1 in each group was detected by Western blot and real time quantitative PCR (qRT-PCR). The proliferation of SGC-7901 cells was detected by colony formation assay. The migration of SGC-7901 cells was detected by TranswellTM migration assay. Human peripheral blood mononuclear cells adoptive NCG immunodeficiency mouse (PBMCs-NCG) subcutaneous tumor model was constructed to observe the tumor growth in mice. The mice were divided into control group, GCMSCs-CM treatment group, VGLL4 knockdown group, and VGLL4 knockdown followed by GCMSCs-CM treatment group. VGLL4 and PD-L1 mRNA levels of tumor tissue were detected by qRT-PCR. Immunohistochemical staining was used to detect the expression of VGLL4, PD-L1, ki67, CD8 and granzyme B (GZMB). Results VGLL4 is expressed in SGC-7901, HGC-27 and MGC-803 cells. The expression of PD-L1 mRNA and protein decreased significantly in SGC-7901 and HGC-27 cells transfected with siVGLL4. The expression of PD-L1 mRNA and protein was up-regulated after overexpression of VGLL4 in SGC-7901 cells. The expression of VGLL4 increased after GCMSCs-CM treatment of HGC-27 and MGC-803 cells. Inhibition of VGLL4 in HGC-27 could reverse the up-regulation of PD-L1 by GCMSCs-CM. Inhibition of VGLL4 in SGC-7901 weakened the ability of GCMSCs-CM to promote cell proliferation and migration. Knockdown of VGLL4 inhibited the effect of GCMSCs-CM in promoting tumor growth in mice and enhanced the anti-tumor immunity of PBMCs-NCG mice. Conclusion GCMSCs-CM promotes the expression of PD-L1 and tumor growth by upregulating VGLL4 in gastric cancer cells.
Similar articles
-
Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.Theranostics. 2020 Oct 25;10(26):11950-11962. doi: 10.7150/thno.49717. eCollection 2020. Theranostics. 2020. PMID: 33204322 Free PMC article.
-
Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression.Gastric Cancer. 2023 Sep;26(5):691-707. doi: 10.1007/s10120-023-01405-1. Epub 2023 Jun 10. Gastric Cancer. 2023. PMID: 37300724
-
Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis.Cell Death Dis. 2018 Sep 11;9(9):928. doi: 10.1038/s41419-018-0988-9. Cell Death Dis. 2018. PMID: 30206229 Free PMC article.
-
eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.BMC Cancer. 2021 Sep 15;21(1):1022. doi: 10.1186/s12885-021-08749-w. BMC Cancer. 2021. PMID: 34525951 Free PMC article.
-
FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression.Int Immunopharmacol. 2025 Jan 10;144:113697. doi: 10.1016/j.intimp.2024.113697. Epub 2024 Nov 29. Int Immunopharmacol. 2025. PMID: 39615112
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials